Accession Number : ADA188226
Title : Army Drug Development Program. Phase 1. Clinical Testing.
Descriptive Note : Final rept. 19 Aug 83-20 Apr 84,
Corporate Author : BIO-MED INC GAMBRILLS MD
Personal Author(s) : Reba, Richard C ; Barry, Kevin G
PDF Url : ADA188226
Report Date : Apr 1985
Pagination or Media Count : 7
Abstract : This is the final report of contract DAMD17-83-C-3001 under which BIO-MED, Inc. was involved in the following activities: The development of protocols for Phase I Clinical Studies and the administrative and technical processing of these protocols. Analysis, interpretation and reporting of the results of studies. Keywords: Pharmacokinetics, Anti-Malarials, Pyridostigmine, Abate, WR 194,965, Acetylcholinesterase Assays, WR 6026.
Descriptors : *PHARMACOKINETICS, *ANTIMALARIALS, ACETYLCHOLINESTERASE, ARMY, CLINICAL MEDICINE, DRUGS, MANAGEMENT, PHASE STUDIES, PROCESSING, TEST AND EVALUATION, BIOASSAY
Subject Categories : Pharmacology
Distribution Statement : APPROVED FOR PUBLIC RELEASE